The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastro-esophageal junction cancer (AGC): A double-blinded, randomized, phase III trial.
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Min-Hee Ryu
No Relationships to Disclose
 
Yee Chao
No Relationships to Disclose
 
Ken Kato
Honoraria - Bristol-Myers Squibb; Dainippon Sumitomo Pharma; Lilly; Nippon Kayaku; Pfizer; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Kyowa Hakko Kirin; Lilly; Merck Serono; MSD; Nippon Kayaku; Novartis; Otsuka; Taiho Pharmaceutical
Research Funding - Merck Serono; MSD; Ono Pharmaceutical; Shionogi
 
Hyun Cheol Chung
Honoraria - Lilly; Merck Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Celltrion; Lilly; MSD; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Lilly; Merck Serono
Research Funding - GlaxoSmithKline; Lilly; MSD
 
Jen-Shi Chen
Consulting or Advisory Role - Lilly; Novartis; Ono Pharmaceutical; TTY Biopharm
Speakers' Bureau - Lilly; MSD; Novartis; TTY Biopharm
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Won Ki Kang
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Sang Cheul Oh
No Relationships to Disclose
 
Takao Tamura
Research Funding - Ono Pharmaceutical (Inst)
 
Keun-Wook Lee
Research Funding - AstraZeneca (Inst); Green Cross (Inst); MSD (Inst)
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Li-Tzong Chen
Honoraria - Bayer; Lilly; Merck Serono; Novartis; PharmaEngine; TTY Biopharm
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merrimack; MSD; Ono Pharmaceutical; Shire
Research Funding - GlaxoSmithKline; Merck Serono; Novartis; Polaris; Taiho Pharmaceutical; TTY Biopharm